Skip to main content
. 2022 Feb 11;12:e2021355. doi: 10.4322/acr.2021.355

Figure 3. A– Cytoplasmic inhibin positivity in tumor cells (40X); B – Nuclear and cytoplasmic calretinin positivity in tumor cells (40X); C– Nuclear PR positivity in tumor cells (40X). D – Nuclear WT1 positivity in tumor cells (40X).

Figure 3